Three U.S. sites in January began recruiting patients to test the safety and efficacy of an intravascular MRI catheter that preclinically differentiates the lipid-rich core of vulnerable plaque from other components.
Three U.S. sites in January began recruiting patients to test the safety and efficacy of an intravascular MRI catheter that preclinically differentiates the lipid-rich core of vulnerable plaque from other components. If proven effective, the technique could dramatically change treatment options for patients with coronary artery disease, according to principal investigator Dr. Ron Waksman, associate chief of cardiology at Washington Hospital Center in Washington, DC.
The objective of TOP-IMAGE II, which intends to enroll 100 subjects, is to assess the safety and functional performance of the device in patients whose plaques are not associated with high-grade stenosis.
Waksman, who spoke at the 2007 International Symposium on Endovascular Therapy, said intravascular ultrasound cannot visualize vulnerable plaques' fibrous cap and is only 37% sensitive for detecting plaque rupture. TopSpin Medical of Israel makes the IntraVascular MRI catheter.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.